Eran Seger

Eran Seger is the CEO and Co-founder of Protai, an AI-powered drug discovery startup based in Tel Aviv, Israel.12 Protai combines deep proteomics research with machine learning to combat complex diseases and improve drug discovery processes.1

Professional Background

Eran Seger has experience as an entrepreneur and tech executive. He is an alumnus of the Israeli intelligence corps, which has likely contributed to his expertise in technology and data analysis.3 Before co-founding Protai, Seger held the position of Vice President at another company.6

Protai Leadership

At Protai, Eran Seger works alongside his co-founder Kirill Pevzner, who serves as the company's CTO.12 Together, they lead a team focused on leveraging artificial intelligence and proteomics to advance the field of drug discovery.

Company Mission

Under Seger's leadership, Protai aims to:

• Merge technology with biology to create transformative solutions4
• Use AI and machine learning to analyze proteomics data
• Improve the understanding and treatment of complex diseases
• Contribute to creating a healthier world through innovative drug discovery methods1

Recruitment and Growth

As CEO, Eran Seger is actively involved in growing the Protai team. He has been known to post about hiring opportunities, seeking passionate individuals in fields such as computational biology, precision medicine, proteomics, and AI.5

Eran Seger's LinkedIn profile can be found under the username eran-seger-8851a128, where he maintains over 500 connections in his professional network.4